BioSpace News Archive

Nordic Nanovector ASA announces that its Interim CEO, Dr Lars Nieba will present a corporate overview via live webcast at DNB’s 11th Annual Nordic Healthcare Conference, taking place on 15 December 2020.

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, announced results presented at the 62nd annual meeting American Society of Hematology, which provide in vivo biomarker evidence linking remestemcel-L’s immunomodulatory activity to survival outcomes in children with steroid-refractory acute graft versus host disease.

Accelerates milestone payments to Nabriva, including fourth quarter 2020payment of $1 million

Prof. Rathore is the first researcher in India to receive this award; he has been recognized for his contributions to biopharmaceutical research

Facet-related spinal pain for non-specific low back pain pose considerable challenge for radiologists and clinicians in finding the right set of interventional tools.

Increasing cases of cancers in all worldwide locations is estimated to boost sales opportunities in the global non-invasive cancer therapies market during the tenure of 2020 to 2030.

Optic nerve disorder is widely known as optic neuropathy, which is medical condition indicating at a gradual degeneration of the optic nerve.

The global osteoporosis testing market is likely to gain from the increasing cases of osteoporosis worldwide.

The global surgical helmet systems market is likely to show upward graph of demand during the forecast period 2020–2030.

Microbial identification has become an important aspect of the overall healthcare domain. With the growing prevalence of infectious diseases, increasing frequency of global pandemic, and rising food safety concerns the need for rapid and reliable microbial identification has become highly important.